retatrutide nonalcoholic fatty liver disease trial Researchers are reporting promising results from studies on an experimental medication called retatrutide, which may help reduce fat while improving overall metabolic health. 🧬⚡ Excess liver fat is a key feature Retatrutide vs semaglutide: complete comparison

They found that the two are related, but that doesnt mean we understand why, says Vicente Diaz, MD, Yale Medicine ophthalmologist and assistant professor of ophthalmology and visual science at Yale School of Medicine

Who its for May be a fit if you Have reached your weight goal and want to maintain Want a lower-dose, maintenance-style approach Prefer month-to-month flexibility Want licensed provider oversight and ongoing support Not the right fit if you Are just starting and want active weight loss (consider full-dose GLP-1) Have a personal or family history of medullary thyroid carcinoma or MEN 2 Are pregnant, trying to conceive, or breastfeeding Are advised against GLP-1 care by your provider Eligibility is always determined by a licensed provider after reviewing your intake

Mollan SP, Mitchell JL, Ottridge RS, et al

[DOI] [PubMed] [Google Scholar] 132.Obici S, Feng Z, Arduini A, Conti R, Rossetti L

They are where GLP-1 is made, cut from a precursor protein called proglucagon